Form 8-K - Current report:
SEC Accession No. 0001558370-25-008742
Filing Date
2025-06-20
Accepted
2025-06-20 08:04:49
Documents
12
Period of Report
2025-06-18
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20250618x8k.htm   iXBRL 8-K 66472
  Complete submission text file 0001558370-25-008742.txt   176724

Data Files

Seq Description Document Type Size
2 EX-101.SCH bpmc-20250618.xsd EX-101.SCH 3453
3 EX-101.LAB bpmc-20250618_lab.xml EX-101.LAB 15251
4 EX-101.PRE bpmc-20250618_pre.xml EX-101.PRE 9842
14 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20250618x8k_htm.xml XML 4673
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 251059134
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)